|
Volumn 36, Issue 2 SUPPL., 2004, Pages S574-S576
|
Future directions in immunosuppression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
CALCINEURIN INHIBITOR;
CYCLOSPORIN A;
DACLIZUMAB;
INTERLEUKIN 2 RECEPTOR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RAPAMYCIN;
TACROLIMUS;
AREA UNDER THE CURVE;
ATHEROSCLEROSIS;
CLINICAL TRIAL;
DIABETES MELLITUS;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG MONITORING;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY DISEASE;
LIVER TRANSPLANTATION;
MORBIDITY;
MORTALITY;
NEPHROTOXICITY;
NEUROLOGIC DISEASE;
PRIORITY JOURNAL;
REVIEW;
RISK FACTOR;
|
EID: 1642316991
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.01.044 Document Type: Article |
Times cited : (6)
|
References (29)
|